20
Participants
Start Date
October 8, 2024
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2026
Neoadjuvant Chemotherapy (NACT)
Two cycles of carbonilumab plus TP regimen neoadjuvant chemotherapy will be implemented to patients with advanced cervical cancer
maintenance therapy
one years of maintenance therapy with carbonilumab alone will be implemented to patients with advanced cervical cancer receiving standard concurrent chemoradiotherapy
Hubei Cancer Hospital, Wuhan
Collaborators (1)
Yichang Central People's Hospital
OTHER
Akeso Pharmaceuticals, Inc.
OTHER
Hubei Cancer Hospital
OTHER